Understanding the cause of type 2 diabetes
- PMID: 39038473
- DOI: 10.1016/S2213-8587(24)00157-8
Understanding the cause of type 2 diabetes
Erratum in
-
Correction to Lancet Diabetes Endocrinol 2024; published online July 19. https://doi.org/10.1016/S2213-8587(24)00157-8.Lancet Diabetes Endocrinol. 2024 Sep;12(9):e18. doi: 10.1016/S2213-8587(24)00244-4. Epub 2024 Aug 1. Lancet Diabetes Endocrinol. 2024. PMID: 39098313 No abstract available.
Abstract
Type 2 diabetes has long been thought to have heterogenous causes, even though epidemiological studies uniformly show a tight relationship with overnutrition. The twin cycle hypothesis postulated that interaction of self-reinforcing cycles of fat accumulation inside the liver and pancreas, driven by modest but chronic positive calorie balance, could explain the development of type 2 diabetes. This hypothesis predicted that substantial weight loss would bring about a return to the non-diabetic state, permitting observation of the pathophysiology determining the transition. These changes were postulated to reflect the basic mechanisms of causation in reverse. A series of studies over the past 15 years has elucidated these underlying mechanisms. Together with other research, the interaction of environmental and genetic factors has been clarified. This knowledge has led to successful implementation of a national programme for remission of type 2 diabetes. This Review discusses the paucity of evidence for heterogeneity in causes of type 2 diabetes and summarises the in vivo pathophysiological changes, which cause this disease of overnutrition. Type 2 diabetes has a homogenous cause expressed in genetically heterogenous individuals.
Copyright © 2024 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Conflict of interest statement
Declaration of interests I report grants from Diabetes UK, having received lecture fees and expenses from Eli Lilly and Abbott Laboratories outside the submitted work, and that I am an advisor to Fast800. I was a member of the Low Carbohydrate Working Group of the UK Government Scientific Advisory Committee on Nutrition and am a member of the advisory group for NHS England Type 2 Diabetes Path to Remission Programme, but all opinions expressed are personal and not representative of these bodies.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
